Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany86404-63-9 2',4'-Difluoro-2-(1H-1,2,4-triazol-1-yl)-acetophenone 98%
2',4'-Difluoro-2-(1H-1,2,4-triazol-1-yl)-acetophenone
2',4'-Difluoro-2-(1H-1,2,4-triazol-1-yl)-acetophenone
2',4'-Difluoro-2-(1H-1,2,4-triazol-1-yl)-acetophenone

86404-63-9 2',4'-Difluoro-2-(1H-1,2,4-triazol-1-yl)-acetophenone 98%

Price Get Latest Price
Packge 1MT1kg5kg10kg25kg
  • Min. Order:1MT
  • Time:2024-02-26

Product Details

  • Product Name2',4'-Difluoro-2-(1H-1,2,4-triazol-1-yl)-acetophenone
  • CAS No.86404-63-9
  • EINECS No.617-850-9
  • MFC10H7F2N3O
  • MW223.18
  • AppearanceSolidWhite to pale brown
  • Melting point 103-107 °C(lit.)
  • storage temp. 2-8°C
  • Boiling point 388.0±52.0 °C(Predicted)
  • density 1.39±0.1 g/cm3(Predicted)

Company Profile Introduction

We are currently engaged in manufacturing bulk drugs & intermediates for the Pharmaceutical industries, fortified with a vision to be a reliance partner with global pharmaceutical companies and dedicated to continuous improvement of product quality and quantity.

We strive for:

  • Ensuring continuous improvement for a sustainable long term competitive advantage.
  • Enhancing competency and skills of our personnel.
  • Generate confidence and building a committed & trusted partnership with our customers.
  • Achieving customer delight.
  • Development and sale of our own intermediates and API to global generic players



Board of Directors:
The Company M/s. LAKSHMIDURGA DRUGS & INTERMEDIATES PVT. LTD. promoted by first generation entrepreneurs Mr. R. Vijaya Krishna & Mr. D. Saibabu driven by high ethical values with an objective of setting up a manufacturing unit for production of APIs, Bulk Drugs & Intermediates.

  • Since:2021-02-01
  • Address: Plot No.541, Ground floor, Near senior citizen park, Vivekananda nagar colony, Kukatpally, Hyderabad
INQUIRY